Novonix Says ASX Granted Waivers Ahead of Aug. 17 Share-Purchase Plan Results

Novonix Limited said July 6, 2026, that the Australian Securities Exchange granted waivers related to the battery-materials company’s previously announced share-purchase plan. Novonix expects to announce the plan’s results on or about Aug. 17, creating a defined capital-markets deadline for a company with operations and investors spanning Australia and the United States.

The disclosure was filed through the U.S. Securities and Exchange Commission’s EDGAR system. It identifies Novonix as headquartered in Brisbane, Australia, and describes the company’s synthetic-graphite anode-materials business and operations in Chattanooga, Tennessee.

What changed

The ASX waivers relate to a share-purchase plan Novonix announced June 17, 2026. The company’s July 6 disclosure did not say that the plan had been completed, fully subscribed or otherwise settled. Instead, it provided the expected timing for the results announcement.

That distinction matters. The waiver disclosure records an exchange-related development, while the amount raised and the level of investor participation remain pending. The filing does not give a final fundraising amount or say how many investors took part.

Novonix’s shares are listed on both NASDAQ and the ASX, according to the filing. The dual-market presence links the company’s financing announcement to investors in both the United States and Australia, although the disclosure itself does not establish how markets will respond.

Why the deadline matters

Novonix produces synthetic graphite anode materials for lithium-ion batteries. The company identifies energy storage, electric vehicles and industrial applications as its stated markets. Those activities place the company within the battery supply chain, where access to capital can matter for a business operating across jurisdictions and serving multiple end markets.

The Aug. 17 target is therefore more than a calendar update for investors. It is the next point at which the company is expected to provide information about participation in its financing plan. That result may help clarify Novonix’s near-term funding position, but the current filing does not provide enough information to determine the plan’s commercial success or its effect on battery-materials demand.

The company’s U.S. footprint is centered in Chattanooga, Tennessee, while its headquarters are in Brisbane. The filing’s description of the company’s business connects those locations to a battery-materials strategy focused on synthetic graphite and lithium-ion battery applications. It does not, however, announce a new plant, a new customer, a change in production capacity or a shift in market demand.

What happens next

Novonix is expected to announce the share-purchase plan’s results on or about Aug. 17, 2026. That announcement should provide the next substantive update on investor participation and the financing outcome.

Until then, the July 6 filing supports only a narrower conclusion: the ASX granted waivers connected with the plan announced June 17, and Novonix set an expected date for reporting its results. It does not establish that the plan raised a particular sum, that it was fully subscribed or that the company’s broader business outlook has changed.

For readers tracking battery supply chains, the upcoming results may offer a clearer view of how investors are responding to Novonix’s capital needs. The available disclosure, however, remains a company announcement and should be read as a schedule and exchange-waiver update rather than an independent assessment of the company’s financial performance.